FDA-approved Mounjaro (tirzepatide) is a GLP-1 medication used for treating diabetes in adults who have a body mass index (BMI) over 27, have hypertension or dyslipidemia, or are obese ( BMI over 30)
The impact on hunger and portion sizes varies from person to person, and while some people notice these changes quickly, others may take longer to experience a significant reduction in appetite
Both are essential for cellular health, but they address different aspects of the longevity equation
We are prepared for a full US launch in early January 2026, with manufacturing well underway in our North Carolina facilities." The FDA approval of Wegovy pill is based on the results from the OASIS 4 phase 3 clinical trial, which was a 64-week medical study that included 307 adults with obesity or overweight with one or more weight-related comorbidities, without diabetes
Sleep: Adults should get between 7 to 9 hours of sleep nightly